Chaplia O, Mathyk B, Nichols-Burns S, Basar M, Halicigil C
Reprod Biol Endocrinol. 2024; 22(1):123.
PMID: 39394617
PMC: 11468284.
DOI: 10.1186/s12958-024-01290-y.
Cascante S, Grifo J, Licciardi F, Parra C, Kelly A, Berkeley A
J Assist Reprod Genet. 2024; 41(11):2979-2985.
PMID: 38955888
PMC: 11621243.
DOI: 10.1007/s10815-024-03175-w.
Pantos K, Maziotis E, Trypidi A, Grigoriadis S, Agapitou K, Pantou A
J Clin Med. 2024; 13(9).
PMID: 38731179
PMC: 11084263.
DOI: 10.3390/jcm13092651.
Fu X, Zhang Y, Gao S, Gao S, Zhang M, Gao S
Front Endocrinol (Lausanne). 2023; 14:1221308.
PMID: 37867517
PMC: 10585140.
DOI: 10.3389/fendo.2023.1221308.
Sandhu S, Hickey M, Lew R, Hammarberg K, Braat S, Agresta F
BMC Med Inform Decis Mak. 2023; 23(1):83.
PMID: 37147687
PMC: 10161420.
DOI: 10.1186/s12911-023-02178-4.
The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study.
Lee K, Lin M, Hwu Y, Yang J, Lee R
J Ovarian Res. 2023; 16(1):49.
PMID: 36869354
PMC: 9983267.
DOI: 10.1186/s13048-023-01128-y.
Oocyte Cryopreservation at a Young Age Provides an Effective Strategy for Expanding Fertile Lifespan.
Poli M, Capalbo A
Front Reprod Health. 2022; 3:704283.
PMID: 36304057
PMC: 9580690.
DOI: 10.3389/frph.2021.704283.
High-security closed devices are efficient and safe to protect human oocytes from potential risk of viral contamination during vitrification and storage especially in the COVID-19 pandemic.
Porcu E, Tranquillo M, Notarangelo L, Ciotti P, Calza N, Zuffa S
J Assist Reprod Genet. 2021; 38(3):681-688.
PMID: 33432422
PMC: 7799863.
DOI: 10.1007/s10815-021-02062-y.
What impact does oocyte vitrification have on epigenetics and gene expression?.
Barberet J, Barry F, Choux C, Guilleman M, Karoui S, Simonot R
Clin Epigenetics. 2020; 12(1):121.
PMID: 32778156
PMC: 7418205.
DOI: 10.1186/s13148-020-00911-8.
Postponing Pregnancy Through Oocyte Cryopreservation for Social Reasons: Considerations Regarding Clinical Practice and the Socio-Psychological and Bioethical Issues Involved.
Simopoulou M, Sfakianoudis K, Bakas P, Giannelou P, Papapetrou C, Kalampokas T
Medicina (Kaunas). 2018; 54(5).
PMID: 30366459
PMC: 6262467.
DOI: 10.3390/medicina54050076.
Counseling patients on reproductive aging and elective fertility preservation-a survey of obstetricians and gynecologists' experience, approach, and knowledge.
Fritz R, Klugman S, Lieman H, Schulkin J, Taouk L, Castleberry N
J Assist Reprod Genet. 2018; 35(9):1613-1621.
PMID: 30073435
PMC: 6133816.
DOI: 10.1007/s10815-018-1273-7.
Outcome of Oocyte Vitrification Combined with Microdissection Testicular Sperm Extraction and Aspiration for Assisted Reproduction in Men.
An G, Zou Z, Flannigan R, Liu J, Du H, Fu X
Med Sci Monit. 2018; 24:1379-1386.
PMID: 29511156
PMC: 5853179.
DOI: 10.12659/msm.909026.
RNA-Seq transcriptome profiling of mouse oocytes after in vitro maturation and/or vitrification.
Gao L, Jia G, Li A, Ma H, Huang Z, Zhu S
Sci Rep. 2017; 7(1):13245.
PMID: 29038524
PMC: 5643491.
DOI: 10.1038/s41598-017-13381-5.
New Promising Strategies in Oncofertility.
Hudson J, Stanley N, Nahata L, Bowman-Curci M, Quinn G
Expert Rev Qual Life Cancer Care. 2017; 2(2):67-78.
PMID: 28959743
PMC: 5612405.
DOI: 10.1080/23809000.2017.1308808.
Propensity score-matched study and meta-analysis of cumulative outcomes of day 2/3 versus day 5/6 embryo transfers.
Yin Y, Chen G, Li K, Liao Q, Zhang S, Ma N
Front Med. 2017; 11(4):563-569.
PMID: 28744794
DOI: 10.1007/s11684-017-0535-6.
A comparison of live birth rates and perinatal outcomes between cryopreserved oocytes and cryopreserved embryos.
Ho J, Woo I, Louie K, Salem W, Jabara S, Bendikson K
J Assist Reprod Genet. 2017; 34(10):1359-1366.
PMID: 28718080
PMC: 5633580.
DOI: 10.1007/s10815-017-0995-2.
Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
Crawford S, Boulet S, Kawwass J, Jamieson D, Kissin D
Fertil Steril. 2016; 107(1):110-118.
PMID: 27842997
PMC: 5590714.
DOI: 10.1016/j.fertnstert.2016.10.002.
Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance.
Rienzi L, Gracia C, Maggiulli R, LaBarbera A, Kaser D, Ubaldi F
Hum Reprod Update. 2016; 23(2):139-155.
PMID: 27827818
PMC: 5850862.
DOI: 10.1093/humupd/dmw038.
Closed vitrification of human oocytes and blastocysts: outcomes from a series of clinical cases.
Gook D, Choo B, Bourne H, Lewis K, Edgar D
J Assist Reprod Genet. 2016; 33(9):1247-52.
PMID: 27233650
PMC: 5010806.
DOI: 10.1007/s10815-016-0748-7.
Vitrification of in vitro matured oocytes diminishes embryo development potential before but not after embryo genomic activation.
Sun Y, Gu R, Lu X, Zhao S, Feng Y
J Assist Reprod Genet. 2015; 33(2):231-6.
PMID: 26685678
PMC: 4759011.
DOI: 10.1007/s10815-015-0637-5.